GLG News by Neonatal-Perinatal Physicians (US)

Targeting a part of the influenza virus which does not mutate or a regular basis is a great idea. If the clinical data supports its efficacy, it would, indeed, be a novel approach to influenza vaccination.

Just as dissatisfaction with procedures in physicians' offices and hospitals has led to increased regulation (OSHA, CLIA, etc.), so will the inevitable problems which will show up in retail clinics lead to more cumbersome regulation.

A new advertising motto--"Always ready!"         

This is not likely to have any significant effect. Chances are that licensing will be pretty much pro-forma (unless they decide to require a certain amount of scientific schooling and background) so licensing will just be another layer of governmental interference.

Ever had a sore arm for two days following a tetanus vaccine?

Hmmmmm. I might as well retire given this choice. Sounds like a lose-lose situation to me

The use of an immunodrug to provide more reliable and long-lasting relief to those among us who suffer from house dust mite and cat allergy--what an improvement this would be.    

-Bharat has gotten approval in India to sell 2 vaccinations that are used for children -Approval in India means only that the drugs can be sold and used in India -Although the Indian market is large, there may be many competing approved products already available in India and this has little implication...

With the availability of desmopressin tablets, the treatment of primary nocturnal enuresis in pediatrics has moved away from the intranasal route, which is the highest risk means of delivering the drug.

The study compared amoxicillin as the antibiotic used in the treatment group with controls with no antibiotic and with nasal steroids. Amoxicillin is not the antibiotic of choice for sinusitis, however.